867MO Epigenetic therapy modulates the tumor microenvironment to sensitize anti-PD-1 refractory head and neck cancers to immunotherapy

Autor: Pai, S., Qin, T., Mattox, A., Campbell, J., Park, J.C., Shin, K-Y., Sadow, P., Faquin, W., Haddad, R., Pittet, M., Garris, C., Mempel, T., Oneill, A., Sartor, M.

Publikováno v: In Annals of Oncology September 2024 35 Supplement 2:S617-S617

'I feel empowered': women's perspectives on and experiences with long-acting injectable antiretroviral therapy in the USA and Spain

Autor: Mantsios A, Murray M, Karver TS, Davis W, Margolis D, Kumar P, Swindells S, Bredeek UF, Deltoro MG, García RR, Antela A, Garris C, Shaefer M, Gomis SC, Bernáldez MP, Kerrigan D

Publikováno v: CULTURE HEALTH & SEXUALITY
r-FIHGUV. Repositorio Institucional de Producción Científica de la Fundación de Investigación del Hospital General de Valencia
instname

Long-acting injectable antiretroviral therapy has been shown to be non-inferior to daily oral antiretroviral therapy in clinical trials and may soon become part of clinical care. While most trial participants to date have been men, approximately one

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=RECOLECTA___::8c19f55908ec79cc246fb7216180e894
https://fundanet.fihgu.san.gva.es/publicaciones/ProdCientif/PublicacionFrw.aspx?id=1651

Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.

PB4 Patient Perspectives on Implementation of a Long-Acting Injectable Antiretroviral Therapy Regimen in HIV US Healthcare Settings: Final Month 12 Results from the CUSTOMIZE Study

Autor: Flamm, J., Garris, C., D'Amico, R., Dalessandro, M., McHorney, C.A., Mansukhani, S.G., Benson, P., Thedinger, B., Salazar, D., Tanda, N., Fricker, J., Czarnogorski, M.

Publikováno v: In Value in Health June 2021 24 Supplement 1:S13-S13

Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.